Actuarial Model Assumptions for Australian Inflation, Equity Returns, and Interest Rates

Though actuaries have developed several types of stochastic investment models for inflation, stock market returns, and interest rates, there are two commonly used in practice: autoregressive time series models with normally distributed errors, and autoregressive conditional heteroscedasticity (ARCH) models. ARCH models are particularly suited when there is heteroscedasticity in inflation and interest rate series. In such cases nonnormal residuals are found in the empirical data. This paper examines whether Australian univariate inflation and interest rate data are consistent with autoregressive time series and ARCH model assumptions

Effect of Additives on the Stereochemical Integrity and Reactivity of α-Alkoxycarbonyl Alkenylcopper Intermediates. Optimal Conditions for the Synthesis of Isomerically Pure Tetrasubstituted Alkenes

A systematic study on the effect of additives on the isomerizability of 1-alkoxycarbonyl alkenylcopper(I) intermediates revealed that the lithium chelator 12-crown-4 is significantly more efficient than HMPA at retarding isomerization. On the other hand, 12-crown-4 alone is unable to promote effective coupling with alkyl halides. The combination of 12-crown-4 and a reduced amount of HMPA, however, led to an improved procedure for the preparation of useful, isomerically pure tetrasubstituted alkenes such as allylation reagents and skipped dienes

Table_1_Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease.docx

ObjectiveUrsodeoxycholic acid (UDCA) may reduce susceptibility to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection by downregulating angiotensin-converting enzyme 2 (ACE2), based on recent experimental investigation. This study aimed to determine the potential protective effect of UDCA against SARS-CoV-2 infection in patients with chronic liver disease.MethodsPatients with chronic liver disease receiving UDCA (taking UDCA ≥1 month) at Beijing Ditan Hospital between January 2022 and December 2022 were consecutively enrolled. These patients were matched in a 1:1 ratio to those with liver disease not receiving UDCA during the same period by using a propensity score matching analysis with nearest neighbor matching algorithm. We conducted a phone survey of coronavirus disease 2019 (COVID-19) infection during the early phase of the pandemic liberation (from 15 December 2022 to 15 January 2023). The risk of COVID-19 was compared in two matched cohorts of 225 UDCA users and 225 non-UDCA users based on patient self-report.ResultsIn the adjusted analysis, the control group was superior to the UDCA group in COVID-19 vaccination rates and liver function indicators, including γ-glutamyl transpeptidase and alkaline phosphatase (p ConclusionUDCA therapy may be beneficial in reducing COVID-19 infection risk, alleviating symptoms, and shortening the recovery time in patients with chronic liver disease. However, it should be emphasized that the conclusions were based on patient self-report rather than classical COVID-19 detection by experimental investigations. Further large clinical and experimental studies are needed to validate these findings.</p

Copper-Catalyzed Intermolecular Trifluoromethylazidation and Trifluoromethylthiocyanation of Allenes: Efficient Access to CF₃‑Containing Allyl Azides and Thiocyanates

A mild and efficient method for copper-catalyzed tri­fluoro­methyl­azidation and tri­fluoro­methyl­thio­cyanation of allenes was explored. A series of CF₃-containing allyl azides and thiocyanates were obtained with high yields and good stereoselectivities, which can be used for further transformation to some valuable compounds

Image_1_Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease.tif

ObjectiveUrsodeoxycholic acid (UDCA) may reduce susceptibility to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection by downregulating angiotensin-converting enzyme 2 (ACE2), based on recent experimental investigation. This study aimed to determine the potential protective effect of UDCA against SARS-CoV-2 infection in patients with chronic liver disease.MethodsPatients with chronic liver disease receiving UDCA (taking UDCA ≥1 month) at Beijing Ditan Hospital between January 2022 and December 2022 were consecutively enrolled. These patients were matched in a 1:1 ratio to those with liver disease not receiving UDCA during the same period by using a propensity score matching analysis with nearest neighbor matching algorithm. We conducted a phone survey of coronavirus disease 2019 (COVID-19) infection during the early phase of the pandemic liberation (from 15 December 2022 to 15 January 2023). The risk of COVID-19 was compared in two matched cohorts of 225 UDCA users and 225 non-UDCA users based on patient self-report.ResultsIn the adjusted analysis, the control group was superior to the UDCA group in COVID-19 vaccination rates and liver function indicators, including γ-glutamyl transpeptidase and alkaline phosphatase (p ConclusionUDCA therapy may be beneficial in reducing COVID-19 infection risk, alleviating symptoms, and shortening the recovery time in patients with chronic liver disease. However, it should be emphasized that the conclusions were based on patient self-report rather than classical COVID-19 detection by experimental investigations. Further large clinical and experimental studies are needed to validate these findings.</p

Image_2_Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease.tif

ObjectiveUrsodeoxycholic acid (UDCA) may reduce susceptibility to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection by downregulating angiotensin-converting enzyme 2 (ACE2), based on recent experimental investigation. This study aimed to determine the potential protective effect of UDCA against SARS-CoV-2 infection in patients with chronic liver disease.MethodsPatients with chronic liver disease receiving UDCA (taking UDCA ≥1 month) at Beijing Ditan Hospital between January 2022 and December 2022 were consecutively enrolled. These patients were matched in a 1:1 ratio to those with liver disease not receiving UDCA during the same period by using a propensity score matching analysis with nearest neighbor matching algorithm. We conducted a phone survey of coronavirus disease 2019 (COVID-19) infection during the early phase of the pandemic liberation (from 15 December 2022 to 15 January 2023). The risk of COVID-19 was compared in two matched cohorts of 225 UDCA users and 225 non-UDCA users based on patient self-report.ResultsIn the adjusted analysis, the control group was superior to the UDCA group in COVID-19 vaccination rates and liver function indicators, including γ-glutamyl transpeptidase and alkaline phosphatase (p ConclusionUDCA therapy may be beneficial in reducing COVID-19 infection risk, alleviating symptoms, and shortening the recovery time in patients with chronic liver disease. However, it should be emphasized that the conclusions were based on patient self-report rather than classical COVID-19 detection by experimental investigations. Further large clinical and experimental studies are needed to validate these findings.</p

Table1_Association of Gut Microbiota and Biochemical Features in a Chinese Population With Renal Uric Acid Stone.DOCX

Previous studies suggest that patients with nephrolithiasis exhibit dysbiosis in their gut microbiota, but those studies were conducted in calcium oxalate stone patients. We aimed to explore the association of gut microbiota and biochemical features of renal uric acid stone (UAS) patients in a Chinese population and identify the related bacteria that may affect the pathopoiesis of UAS. A case-control study of 117 patients with UAS, 123 patients with gout, and 135 healthy controls were included from January 2014 to October 2020. For each subject, data on demographics, biochemical parameters of blood and urine were analyzed. Fifteen patients with gout, 16 patients with UAS, 17 UAS patients with gout, and 17 healthy subjects were enrolled and provided fecal samples. The characteristics of gut microbiota were explored by using 16S ribosomal RNA (rRNA) gene sequencing and analyzed by using a combination of software mother and R. Hyperuricemia was the main risk factor for the development of gout and UAS. Obesity, dyslipidemia, and aciduria were unique risk factors for UAS patients. The richness, diversity, and relative abundance of dominant bacteria at the phylum and genus levels of gut microbiota in UAS patients were significantly distinct from other subjects. Abundance of Bacteroides and Fusobacterium was significantly positively correlated with the serum uric acid (UA) level of UAS patients. Fusobacteria was involved in the metabolism and degradation of certain short-chain fatty acids, amino acids, and sugars in pathopoiesis of UAS, and inhibited their synthesis pathways. Fusobacteria may be related to the pathogenesis of UAS, and this finding contributes to the personalized treatment of UAS from the perspective of maintaining micro-ecological equilibrium in gut.</p

Sunlight-Assisted Degradation of Dye Pollutants in Ag₃PO₄ Suspension

Sunlight-induced photodegradation of rhodamine B over Ag₃PO₄ has been observed. Nanosized Ag₃PO₄ was synthesized by a facile ion-exchange route. X-ray powder diffraction, scanning electron microscopy, X-ray photoelectron spectroscopy, the Brunauer–Emmett–Teller surface area, UV–vis diffuse reflectance spectroscopy and photoluminescence spectra were employed to investigate the phase structure, morphology and optical property of the Ag₃PO₄ product. Nearly 100% of rhodamine B was degraded after a very short irradiation time using simulated sunlight in Ag₃PO₄ suspension, and the total organic carbon measurement revealed that a high degree of mineralization was achieved in the present photocatalytic system. Ag₃PO₄ catalyst has an excellent photocatalytic performance due to the high separation efficiency of electron and hole pairs. In the neutral pH solution, Ag₃PO₄ catalyst exhibited the best photoactivity under simulated sunlight. The photoinduced holes were considered to be the dominant active species in the photodegradation process

Inverse Faraday Effect in an Optomagnonic Waveguide

Single-mode high-index-contrast waveguides have been ubiquitously exploited in optical, microwave, and phononic structures for achieving enhanced wave-matter interactions. Although micro-scale optomechanical and electro-optical devices have been widely studied, optomagnonic devices remain a grand challenge at the microscale. Here, we introduce a planar optomagnonic waveguide platform based on a ferrimagnetic insulator that simultaneously supports single transverse mode of spin waves (magnons) and highly confined optical modes. The co-localization of spin and light waves gives rise to enhanced inverse Faraday effect, and as a result, magnons are excited by an effective magnetic field generated by interacting optical photons. Moreover, the strongly enhanced optomagnonic interaction allows us to observe such effect using low-power (milliwatt level) light signals in the continuous-wave form, as opposed to high-intensity (megawatt peak power) light pulses that are typically required in magnetic bulk materials or thin films. The optically-driven magnons are detected electrically with preserved phase coherence, showing the feasibility for launching spin waves with low-power continuous optical fields

Risk of congenital anomalies for children exposed to PTU& MMI/CMZ.

<p>Risk of congenital anomalies for children exposed to PTU& MMI/CMZ.</p